Evaluating Optimal Operating Table Height for ProSeal-LMA™ Insertion
1 other identifier
interventional
150
1 country
1
Brief Summary
Usage of LMA has gained much importance especially as a rescue device for failed intubation. We hypothesised optimal operating table height could improve successful attempt of ProSeal-LMA™ (P-LMA™) insertion. The main objective of this study is to evaluate the optimal operating table height for successful placement of P-LMA™ by comparing operating table height to operators' body landmark. The secondary objectives of this study are to evaluate duration required for a successful P-LMA™ insertion and its associated complications during the attempt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 6, 2020
CompletedFirst Posted
Study publicly available on registry
April 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedApril 8, 2020
April 1, 2020
1.7 years
April 6, 2020
April 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optimal operating table height for successful placement of P-LMA™
To evaluate optimal operating table height for successful placement of P-LMA™ by comparing operating table height to operators' body landmark
2 years
Secondary Outcomes (2)
Evaluation of time required for a successful P-LMA™ insertion
2 years
Evaluation of associated complications during P-LMA™ insertion
2 years
Study Arms (3)
Group U
ACTIVE COMPARATORPerformers' umbilicus
Group R
ACTIVE COMPARATORPerformers' lowest rib margin
Group X
ACTIVE COMPARATORPerformers' xiphoid process
Interventions
It is a second generation LMA that is commonly used among all other LMAs
Eligibility Criteria
You may qualify if:
- Age between 18 to 65 years old
- American Society of Anesthesiologists (ASA) I-II patients
- Elective and emergency surgeries requiring general anaesthesia where use of P-LMA™ is not contraindicated
You may not qualify if:
- Congenital or acquired airway abnormality
- Cervical spine pathology
- Edentulous or loose tooth
- BMI ≥35 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiti Kebangsaan Malaysia Medical Centre
Kuala Lumpur, 56000, Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 6, 2020
First Posted
April 8, 2020
Study Start
June 1, 2019
Primary Completion
January 31, 2021
Study Completion
May 31, 2021
Last Updated
April 8, 2020
Record last verified: 2020-04